Update in Gastroenterology
Authors: N J Greenberger, M R Gillock, D Kramer, P T Kefalides
Journal: Annals of Internal Medicine (2000)

Updates from the Annual Session3 October 2000Update in GastroenterologyNorton J. Greenberger, MDNorton J. Greenberger, MDFrom University of Kansas Medical Center, Kansas City, Kansas.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-7-200010030-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This Update summarizes important developments published during the past year concerning clinical problems frequently encountered by practicing internists. New points are cited from several of the ongoing debates in the gastroenterology literature. The Update is divided into sections on the esophagus, acid peptic disease and Helicobacter pylori, gastrointestinal effects of cyclooxygenase-2 inhibitors, intestinal disease, cancer, and hepatobiliary disease. In addition, each section includes several “fast facts” to communicate briefly several newsworthy items.Esophageal DisordersGastroesophageal Reflux Disease Was Associated with Increased Risk for Esophageal CancerLagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for ...References1. Ferrer M, Bauer TT, Torres A, Hernandez C, Piera C. Effect of nasogastric tube size on gastroesophageal reflux and microaspiration in intubated patients. Ann Intern Med. 1999;130:991-4. LinkGoogle Scholar2. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Bigisson S, Slaughter RL, et al . Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44:231-9. CrossrefMedlineGoogle Scholar3. Vaira D, Malfertheiner P, Megraud F, Axon AT, Deltenre M, Hirschl AM, et al . Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HsSA European study group. Lancet. 1999;354:30-3. CrossrefMedlineGoogle Scholar4. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al . Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131:88-95. LinkGoogle Scholar5. Peterson WL, Cryer B. COX-1-sparing NSAIDs—is the enthusiasm justified? [Editorial]. JAMA. 1999;282:1961-3. CrossrefMedlineGoogle Scholar6. Colombel JF, Lemann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, et al . A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol. 1999;94:674-8. CrossrefMedlineGoogle Scholar7. Camilleri M, Northcutt AR, King S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000;355:1035-40. CrossrefMedlineGoogle Scholar8. Bardhan KD, Bodemar G, Geldof H, Schutz E, Heath A, Mills JG, et al . A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2000;14:23-34. CrossrefMedlineGoogle Scholar9. Prantera C, Cottone M, Pallone F, Annese V, Franze A, Cerutti R, et al . Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology. 1999;116:521-6. CrossrefMedlineGoogle Scholar10. Cody SH, Glynn MK, Farrar JA, Cairns KL, Griffin PM, Kobayashi J, et al . An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med. 1999;130:202-9. LinkGoogle Scholar11. Bond JH. Virtual colonoscopy—promising, but not ready for widespread use [Editorial]. N Engl J Med. 1999;341:1540-2. CrossrefMedlineGoogle Scholar12. Reddy KR, Levi J, Livingstone A, Jeffers L, Molina E, Kligerman S, et al . Experience with staging laparoscopy in pancreatic malignancy. Gastrointest Endosc. 1999;49:498-503. CrossrefMedlineGoogle Scholar13. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol. 1999;94:3010-4. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Norton J. Greenberger, MDAffiliations: From University of Kansas Medical Center, Kansas City, Kansas.Corresponding Author: Norton J. Greenberger, MD, Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 3 October 2000Volume 133, Issue 7Page: 542-548KeywordsAdenomasCalciumColonoscopyColorectal cancerCrohn's diseaseCyclooxygenase 2EsophagusGastroesophageal reflux diseaseNSAIDsUlcers ePublished: 3 October 2000 Issue Published: 3 October 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...